$10.78
0[0.00%]
Last update: 4:20PM Get Real Time Here
KalVista Pharma
(NASDAQ:KALV)KalVista Pharma Stock (NASDAQ:KALV), Insider Trading Activity
KalVista Pharma: Insider buying and selling updated today.
Insider Shares Owned
596.456K
Insider Percentage Owned
1.41%
Institutional Shares Held
10.149M
Institutional Percentage Held
24.1%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -9.5K | $14.07 | -$397.93K | SELL | -13.26% | 62.157K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | 6.735K | $14.11 | -$170.12K | SELL-OPTIONS | 10.18% | 72.895K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Benjamin L Palleiko | CFO, CBO | 28.227K | $14.11 | -$321.85K | SELL-OPTIONS | 17.74% | 187.315K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Paul Audhya | CHIEF MEDICAL OFFICER | 16.318K | $14.12 | -$201.77K | SELL-OPTIONS | 44.62% | 52.886K | Feb 17 - Feb 20 | View |
| Feb 21, 2024 | Andrew Thomas Crockett | CEO | 29.527K | $14.11 | -$351.29K | SELL-OPTIONS | 16.25% | 211.203K | Feb 17 - Feb 20 | View |
| Feb 16, 2024 | Benjamin L Palleiko | CFO, CBO | -40.855K | $15.01 | -$613.20K | SELL | -20.43% | 159.088K | Feb 14 | View |
| Feb 16, 2024 | Andrew Thomas Crockett | CEO | -58.356K | $15.01 | -$875.88K | SELL | -24.31% | 181.676K | Feb 14 | View |
| Feb 16, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -28.171K | $15.01 | -$422.83K | SELL | -28.22% | 71.657K | Feb 14 | View |
| Feb 16, 2024 | Christopher Yea | CHIEF DEVELOPMENT OFFICER | -39.886K | $15.01 | -$598.66K | SELL | -37.61% | 66.16K | Feb 14 | View |
| Feb 08, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 86.048K | $14.62 | $1.26M | BUY | 1.82% | 4.824731M | Feb 06 - Feb 08 | View |
| Feb 05, 2024 | Andrew Thomas Crockett | CEO | -10K | $16.22 | -$162.20K | SELL | -7.84% | 117.532K | Feb 01 | View |
| Feb 01, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 88.099K | $14.47 | $1.27M | BUY | 1.89% | 4.738683M | Jan 30 | View |
| Jan 29, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 91.804K | $14.05 | $1.29M | BUY | 2.01% | 4.650584M | Jan 25 - Jan 29 | View |
| Jan 24, 2024 | Venrock Healthcare Capital Partners III LPBong KohVHCP CoInvestment Holdings III LLCVHCP Management III LLCVHCP Management EG LLCVenrock Healthcare Capital Partners EG LPNimish Shah | 10% OWNER | 99.129K | $12.53 | $1.24M | BUY | 2.22% | 4.55878M | Jan 22 - Jan 24 | View |
| Jan 19, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 143.605K | $12.55 | $1.80M | BUY | 3.33% | 4.459651M | Jan 17 - Jan 19 | View |
| Jan 16, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 26.246K | $12.72 | $333.78K | BUY | 0.61% | 4.316046M | Jan 11 - Jan 16 | View |
| Jan 12, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -22.679K | $13.03 | -$295.51K | SELL | -36.28% | 39.828K | Jan 11 | View |
| Jan 10, 2024 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners EG LPVHCP Management EG LLCBong KohNimish Shah | 10% OWNER | 137.7K | $12.54 | $1.73M | BUY | 3.32% | 4.2898M | Jan 08 - Jan 10 | View |
| Jan 10, 2024 | Edward Feener | CHIEF SCIENTIFIC OFFICER | -17.321K | $13.01 | -$225.30K | SELL | -21.70% | 62.507K | Jan 08 - Jan 09 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.